Skip to content
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

QT Imaging Holdings, Inc. QTI

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$18.9M
▲ 287.9% YoY
$-21.1M
$-9.1M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 18.9M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 18.9 · Net income -21.1
10M20M-10M-20M
202120242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−111 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -23.4%
-5000%-10000%
202120232025
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -9.1
-5M-10M
202120232025

Total assetsUSD 23.0M
EquityUSD 6.4M
CashUSD 10.4M
Gross debtUSD 10.1M
Net debtUSD -303,000.00
Current ratio2.81×

The company holds more cash than debt.

The 5-year record

5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
QTI, 5-year financial record
Metric 20252024202320222021
Revenue $B0.00.00.00.0◌
Operating income $B−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0◌◌
Income tax $B−0.0−0.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0◌◌
EPS, diluted $−2.01−2.13−0.64−0.60−0.14
Dividend / sh $◌◌◌◌◌
Payout % — not applicable: no dividend—————
ROE % — not applicable: negative equity—————
Shares out B0.010.030.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 23 reconciliationsAUDITED

Reconciled in 5 of the 5 fiscal years we could check. 28 checks were skipped: the balance sheet is not tagged before 2021. 16 checks were skipped: cost of revenue is not tagged before 2023. 14 checks were skipped: EPS is not tagged before 2021.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityElectromedical & Electrotherapeutic Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image